The FDA Has Granted Approval For A New Medication Designed To alleviate pain 2025

On January 30, 2025, the U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine), a novel non-opioid medication developed by Vertex Pharmaceuticals for the treatment of moderate-to-severe acute pain in adults. This approval marks the first new class of pain medications in over two decades, offering an alternative to traditional opioid analgesics. The Opioid Crisis: […]